Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder

ABSTRACTIntroduction: Approximately 50% of adults with major depressive disorder (MDD) who receive a first-line antidepressant treatment, at an appropriate dose, do not achieve an adequate response...